This research-grade peptide is intended for laboratory use only
The 2017 foundational studies confirmed that 5amino1mq reduces NAD consumption via NNMT inhibition, improves glucose clearance, and decreases fat accumulation.In subsequent years, the scope expanded: a 2021 study in obese mice validated its antiobesity effects, and 2024 research revealed improvements in muscle function in aged mice.To date, the compound remains in the preclinical research stage, with no largescale human clinical trials or FDA approval for human use
Both locations are open Monday through Sunday, 10am6pm
Emotional and practical considerations count as well
For background on the research peptide industry as a whole, see The Canadian Peptide Market in 2026
Are you saying that it's not a problem to get B12 anywhere because as far as I know I've been struggling for two years trying to get B12 so I'm not real sure what your comment is about